Prof. Michael Buschmann
George Mason University, United States of Anerica
Michael Buschmann is Chair of the Bioengineering Department at George Mason University in the Washington DC region, since 2017. After receiving a Ph.D. in Medical Engineering and Medical Physics from MIT and Harvard University in 1992, and postdoctoral training from the University of Bern, Switzerland from 1992-1994, he was Professor of Biomedical Engineering and Chemical Engineering at Polytechnique de Montréal until 2017. He led a multifaceted research program in biomaterials for tissue regeneration that resulted in successful clinical translation of a cartilage repair product that is marketed internationally by Smith and Nephew. His more recent research has focused on the delivery of nucleic acids using chitosans, a family of glucosamine-based biopolymers with particular success in delivery of siRNA to the kidney. At his new lab, he is focusing on new technologies to deliver messenger RNA for vaccines and for protein replacement therapies. Dr. Buschmann has over 150 peer-reviewed manuscripts, 20 patent applications (9 granted), an H-index over 60, won 19 research prizes, and founded 3 successful biomedical companies.